Fluoxetine Hydrochloride
Pricing Report NDC 47781-600-30

Latest NADAC: $0.42309 per EA · Effective Jun 19, 2024 · Est. package price $12.69 (30 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Fluoxetine Hydrochloride (NDC 47781-600-30) is $0.42309 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 19, 2024.

As a provided by Alvogen Inc., this medication is distributed in a 30 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.42309
Per EA

Effective Date
Jun 19, 2024
Billable Units
30 EA
Estimated Package Price
$12.69
Data Status
As of Jun 26, 2024
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET, FILM COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2017, the NADAC wholesale price for (NDC ) has moved within a range of $0.33099 to $9.30480 per EA. Over this 6 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.3310 - $9.3048
Market Volatility
2,711.20% Variance
Latest Trend
25.56%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jun 19, 2024 $0.42309 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 22, 2024 $0.33695 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 17, 2024 $0.33099 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 20, 2024 $0.60919 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 21, 2024 $0.62150 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 17, 2024 $0.56116 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 20, 2023 $0.49732 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 22, 2023 $0.65186 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 18, 2023 $0.48948 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 20, 2023 $0.45182 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 23, 2023 $0.53900 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 19, 2023 $0.48040 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026